Powell Andrew Kenneth William

Average Profitability
<0.0001%
Insider Buys Quantity
3
Insider Buys Sum
$37,075.00
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of Powell Andrew Kenneth William

According to the SEC Form 4 filings, Powell Andrew Kenneth William, being in a position of

  1. director at Aclaris Therapeutics, Inc.,
    оver the last 12 months, has bought 14500 shares for $17,955, and sold 0 shares,
    over all time since 2018-05-16, has bought 15500 shares for $37,075, and sold 0 shares.

The largest purchase of all time was on 2018-05-16 and amounted to 1000 shares of Aclaris Therapeutics, Inc. for $19,120.

Biography of Powell Andrew Kenneth William

No biography is available at this moment.

2024-03-04PurchaseAclaris Therapeutics, Inc.
ACRS
director
6,000
0.0083%
$1.25$7,500-3.2%
2024-03-01PurchaseAclaris Therapeutics, Inc.
ACRS
director
8,500
0.0119%
$1.23$10,455-1.63%
2018-05-16PurchaseAclaris Therapeutics, Inc.
ACRS
director
1,000
0.0032%
$19.12$19,120-50.39%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.